Welcome to our dedicated page for Hydrofarm Holdings Group SEC filings (Ticker: HYFM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hydrofarm Holdings Group, Inc. SEC filings document the company’s hydroponics equipment and supplies business, public-company governance and capital structure. Form 8-K reports cover operating results, material agreements, credit arrangements, revolving-credit termination, forbearance matters, auditor changes, executive and board transitions, and Nasdaq continued-listing compliance notices.
Proxy filings describe director elections, board committee matters, executive compensation and equity-award disclosures. The filing record also addresses liquidity, stockholders’ equity, risk factors, financial reporting controls and the debt obligations tied to Hydrofarm’s role as a branded manufacturer and distributor serving controlled environment agriculture markets.
Mark S. Parker, President of Hydrofarm Holdings Group, Inc. (HYFM), reported a routine withholding transaction related to the vesting of restricted stock units. On 08/11/2025 1,667 stock-settled restricted stock units vested and 771 shares were withheld to satisfy tax withholding obligations at an indicated price of $4.49 per share. After the withholding, Mr. Parker beneficially owns 21,370 shares of common stock. The transaction was reported on a Form 4 and reflects a direct, non-derivative change in ownership tied to RSU vesting rather than an open-market sale.
Erica Ackerman, listed as Chief Accounting Officer and Corporate Controller of Hydrofarm Holdings Group, Inc. (HYFM), reported a securities transaction dated 08/11/2025 involving the company’s common stock.
The filing discloses that 333 stock-settled restricted stock units (RSUs) vested and shares were withheld to satisfy the related tax withholding obligation. The withholding activity is shown at a per-share amount of $4.49. After the reported transaction the reporting person is shown as beneficially owning 8,227 shares of common stock directly. The RSUs may be settled 1-for-1 in common shares and fractional amounts were rounded.
Hydrofarm Holdings Group, Inc. reported continued revenue contraction and operating losses for the quarter. Net sales were $39.2 million for the three months ended June 30, 2025 (down 28.4% year-over-year) and $79.8 million for the six months ended June 30, 2025 (down 26.8% year-over-year). Gross profit fell to $2.8 million for the quarter and $9.7 million year-to-date. Net loss was $(16.9) million for the quarter and $(31.2) million for the six months; basic loss per share was $(3.63) and $(6.75), respectively.
The company completed a 1-for-10 reverse stock split effective February 12, 2025, and executed the 2024 IGE asset sale with proceeds that were partially reinvested and used to prepay the Term Loan. Management initiated a 2025 restructuring (Q2 charges of $3.3 million) to reduce product portfolio and footprint and expects annual cost savings in excess of $3.0 million; cash declined to $11.0 million from $26.1 million at year-end. Term Loan principal remains material at ~$111.6 million (net of discounts).
Hydrofarm Holdings Group, Inc. announced on August 12, 2025 that it issued a press release reporting its financial results for the quarter ended June 30, 2025 and provided an earnings presentation on its investor relations website. The press release is furnished as Exhibit 99.1 and the earnings presentation as Exhibit 99.2. Both exhibits are expressly furnished, not filed, and the filing states they are not subject to the liabilities of Section 18 of the Exchange Act.
The Form 8-K identifies the company as a Delaware corporation trading Common Stock (HYFM) on Nasdaq and is signed by Chief Executive Officer B. John Lindeman. The filing also incorporates the press release's Cautionary Note Regarding Forward-Looking Statements into its Regulation FD disclosure and directs investors to https://investors.hydrofarm.com/ for the presentation.